Trending...
- Assent Recognizes Manufacturers for Leading Supply Chain Sustainability Programs
- Dr. Johnny Shanks Attends Full Arch Growth Conference 2025
- Offline Asset Protection: NJTRX Implements 98 Percent Cold Storage as Industry Faces 2 Billion USD Losses
BELLEFONTE, Pa. - PennZone -- Actuated Medical is thrilled to announce the first clinical case of its FDA cleared and patented GripTract-GI endoscopic tissue manipulator. This achievement demonstrates the company's ongoing commitment to advancing minimally invasive medical technologies and improving patient outcomes.
Molham Abdulsamad, MD, FACP, performed an advanced endoscopic procedure called endoscopic submucosal dissection (ESD) during which he leveraged GripTract's innovative design to assist in improving visualization to successfully remove a large complex polyp from a patient's lower gastrointestinal (GI) tract. A notable moment occurred when Dr. Abdulsamad commented to his team, "That's what you want to see," as one of GripTract's fingers provided traction while the other maintained countertraction—allowing for a broad visualization of the resection plane and facilitating a safer, more effective procedure.
In addition to this groundbreaking case, Actuated Medical is proud to announce that GripTract received its third FDA clearance, which adds an upper GI model that further expands its portfolio to provide solutions across the entire GI tract.
More on The PennZone
"These two milestones, achieved on the same day, reflect several years of rigorous development by a dedicated team focused on improving patient outcomes," said Maureen L. Mulvihill, CEO of Actuated Medical. "ESD is a very challenging procedure to master, so better tools like GripTract are necessary to make this procedure available for more patients. GripTract's development was partially supported by a NIH-NIDDK (National Institutes of Health – National Institute of Diabetes and Kidney Diseases) SBIR (Small Business Innovation Research) project. Thanks to NIH, GripTract was available for this patient and many more to follow."
GripTract is being manufactured in central Pennsylvania in Actuated Medical's FDA compliant facility.
About Actuated Medical, Inc.
Actuated Medical is a medical technology innovator that is pioneering motion-based solutions to address critical, unmet clinical needs in gastroenterology and neurology. The team is committed to delivering transformative products that empower healthcare professionals to achieve greater precision, enhance efficiency, and drive better patient outcomes while reducing healthcare costs. The company's technologies are backed by a strategic path to commercialization with multiple exit opportunities, supported by invaluable feedback from industry leaders. Actuated holds 45 issued U.S. and international patents, 9 FDA 510(k) clearances, 5 Investigational Device Exemptions (IDEs), 33 pre-submissions, and has completed or is conducting 8 clinical studies. Actuated has been honored with two Small Business Administration (SBA) Tibbetts Awards for SBIR commercialization excellence (2014 & 2020). Actuated operates out of a state-of-the-art 20,000 sq. ft. facility in central Pennsylvania and is certified with ISO 13485 and as a Woman-Owned Small Business (WOSB), reflecting its steadfast commitment to quality and innovation. actuatedmedical.com
More on The PennZone
###
For media inquiries, please contact Maureen L. Mulvihill, Ph.D. by phone at 814-355-0003 or email at info@actuatedmedical.com.
Additional information can be found by visiting:
ActuatedMedical.com
ActuatedNeuroscience.com
TubeClear.com
GripTract.com
Molham Abdulsamad, MD, FACP, performed an advanced endoscopic procedure called endoscopic submucosal dissection (ESD) during which he leveraged GripTract's innovative design to assist in improving visualization to successfully remove a large complex polyp from a patient's lower gastrointestinal (GI) tract. A notable moment occurred when Dr. Abdulsamad commented to his team, "That's what you want to see," as one of GripTract's fingers provided traction while the other maintained countertraction—allowing for a broad visualization of the resection plane and facilitating a safer, more effective procedure.
In addition to this groundbreaking case, Actuated Medical is proud to announce that GripTract received its third FDA clearance, which adds an upper GI model that further expands its portfolio to provide solutions across the entire GI tract.
More on The PennZone
- Lawproactive Launches Next-Generation CRM, Marrying Data and Location with Geo-Optimized Funnels for Attorney Lead Generation
- POWER SOLUTIONS N.V. Partners with ENERGY33 LLC to Deliver a 40.5 MW Temporary Power Project for ECUACORRIENTE S.A. in Ecuador
- The Quirky Charm Of Unconventional Storytelling
- Pioneering the Future of Human-Computer Interaction Through AI-Powered Neural Input Technology: Wearable Devices Ltd. (N A S D A Q: WLDS)
- Epic Pictures Group Sets North American Release Date for the Action Thriller LOST HORIZON
"These two milestones, achieved on the same day, reflect several years of rigorous development by a dedicated team focused on improving patient outcomes," said Maureen L. Mulvihill, CEO of Actuated Medical. "ESD is a very challenging procedure to master, so better tools like GripTract are necessary to make this procedure available for more patients. GripTract's development was partially supported by a NIH-NIDDK (National Institutes of Health – National Institute of Diabetes and Kidney Diseases) SBIR (Small Business Innovation Research) project. Thanks to NIH, GripTract was available for this patient and many more to follow."
GripTract is being manufactured in central Pennsylvania in Actuated Medical's FDA compliant facility.
About Actuated Medical, Inc.
Actuated Medical is a medical technology innovator that is pioneering motion-based solutions to address critical, unmet clinical needs in gastroenterology and neurology. The team is committed to delivering transformative products that empower healthcare professionals to achieve greater precision, enhance efficiency, and drive better patient outcomes while reducing healthcare costs. The company's technologies are backed by a strategic path to commercialization with multiple exit opportunities, supported by invaluable feedback from industry leaders. Actuated holds 45 issued U.S. and international patents, 9 FDA 510(k) clearances, 5 Investigational Device Exemptions (IDEs), 33 pre-submissions, and has completed or is conducting 8 clinical studies. Actuated has been honored with two Small Business Administration (SBA) Tibbetts Awards for SBIR commercialization excellence (2014 & 2020). Actuated operates out of a state-of-the-art 20,000 sq. ft. facility in central Pennsylvania and is certified with ISO 13485 and as a Woman-Owned Small Business (WOSB), reflecting its steadfast commitment to quality and innovation. actuatedmedical.com
More on The PennZone
- Global Innovators Take the Stage at the WorldUpstart Accelerator Showcase in Philadelphia
- HR Soul Consulting Recognized as a 2025 Inc. Power Partner Award Winner for the Fourth Consecutive Year
- Brazil 021 Chicago Launches New Website and Expands with No-Gi Classes for All Levels
- American Star Guard Unveils a Powerful Rebrand and Expanded Security Services Throughout Nevada
- PlaceBased Media Expands Point-of-Care Advertising Inventory Across U.S. Clinic Network
###
For media inquiries, please contact Maureen L. Mulvihill, Ph.D. by phone at 814-355-0003 or email at info@actuatedmedical.com.
Additional information can be found by visiting:
ActuatedMedical.com
ActuatedNeuroscience.com
TubeClear.com
GripTract.com
Source: Actuated Medical, Inc.
0 Comments
Latest on The PennZone
- Parkchester Oral & Maxillofacial Surgery Celebrates 450+ 5-Star Reviews
- The AI CEO Partners with D3 Hockey News to Elevate the Voice of Division III Hockey Nationwide
- Statement from the Campaign of Theodis Daniel, Republican for U.S. Congress (TX-18)
- Divine Punk Announces Happy Christmas, a Holiday Soundscape by Rebecca Noelle
- $430 Million 2026 Revenue Forecast; 26% Organic Growth; $500,000 Stock Dividend Highlight a Powerful AI & Digital Transformation Story: IQSTEL $IQST
- Wzzph Deploys 5-Million-TPS Trading Engine with Hot-Cold Wallet Architecture Serving 500,000 Active Users Across Latin America
- Preston Dermatology & Skin Surgery Center and Dr. Sheel Desai Solomon Dominate Raleigh's Best Awards from The News & Observer
- $73.6 Million Multi-Year Backlog and Florida State Term Contract Drive Momentum for AI-Cybersecurity Pioneer: Cycurion, Inc. (N A S D A Q: CYCU) $CYCU
- Year-Round Deals for Customers With Square Signs
- SecurePII Raises US$3.5M (A$5M) to Unlock AI and Compliance for Voice Data and Expands Global Presence
- Peter Coe Verbica Stands with Rural Families and Horse Owners: "Keep Horses Classified as Livestock"
- The Mobile-First Company Raises $12M to Build Simple, Powerful Software for Small Teams
- Lick Pineapple Flavored Massage Oil Outperforming and Enticing
- Cerberus ODC in Collaboration with NVIDIA Launches All-American AI-RAN Stack, Enabling AI-Native 5G Today and Accelerating the Path to 6G
- National Compliance Firm issues Artificial Intelligence Policy Program for Mortgage Banking
- Pastor Darrell Armstrong Suspends Gubernatorial Campaign And Endorses Mikie Sherrill
- Dr. Johnny Shanks Attends Full Arch Growth Conference 2025
- Offline Asset Protection: NJTRX Implements 98 Percent Cold Storage as Industry Faces 2 Billion USD Losses
- Thousands of Smiles, Millions of Logo Views: RoarFun Brings Emotions Into Premium Retail Spaces with Formula Simulator for Immersive Brand Activation
- Qvarz LLC Expands Global Reach with High-Precision Quartz Cuvettes and Optical Components
